ATE420190T1 - Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen - Google Patents
Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzenInfo
- Publication number
- ATE420190T1 ATE420190T1 AT96939150T AT96939150T ATE420190T1 AT E420190 T1 ATE420190 T1 AT E420190T1 AT 96939150 T AT96939150 T AT 96939150T AT 96939150 T AT96939150 T AT 96939150T AT E420190 T1 ATE420190 T1 AT E420190T1
- Authority
- AT
- Austria
- Prior art keywords
- perimonitis
- cats
- infectious
- treatment
- live vaccine
- Prior art date
Links
- 241000701087 Felid alphaherpesvirus 1 Species 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000002458 infectious effect Effects 0.000 title 1
- 101000621943 Acholeplasma phage L2 Probable integrase/recombinase Proteins 0.000 abstract 1
- 101000618348 Allochromatium vinosum (strain ATCC 17899 / DSM 180 / NBRC 103801 / NCIMB 10441 / D) Uncharacterized protein Alvin_0065 Proteins 0.000 abstract 1
- 101000781117 Autographa californica nuclear polyhedrosis virus Uncharacterized 12.4 kDa protein in CTL-LEF2 intergenic region Proteins 0.000 abstract 1
- 101000708323 Azospirillum brasilense Uncharacterized 28.8 kDa protein in nifR3-like 5'region Proteins 0.000 abstract 1
- 101000770311 Azotobacter chroococcum mcd 1 Uncharacterized 19.8 kDa protein in nifW 5'region Proteins 0.000 abstract 1
- 101000748761 Bacillus subtilis (strain 168) Uncharacterized MFS-type transporter YcxA Proteins 0.000 abstract 1
- 101000765620 Bacillus subtilis (strain 168) Uncharacterized protein YlxP Proteins 0.000 abstract 1
- 101000916134 Bacillus subtilis (strain 168) Uncharacterized protein YqxJ Proteins 0.000 abstract 1
- 101000754349 Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251) UPF0065 protein BP0148 Proteins 0.000 abstract 1
- 101000827633 Caldicellulosiruptor sp. (strain Rt8B.4) Uncharacterized 23.9 kDa protein in xynA 3'region Proteins 0.000 abstract 1
- 101000947628 Claviceps purpurea Uncharacterized 11.8 kDa protein Proteins 0.000 abstract 1
- 101000686796 Clostridium perfringens Replication protein Proteins 0.000 abstract 1
- 101000788129 Escherichia coli Uncharacterized protein in sul1 3'region Proteins 0.000 abstract 1
- 101000788370 Escherichia phage P2 Uncharacterized 12.9 kDa protein in GpA 3'region Proteins 0.000 abstract 1
- 101000787096 Geobacillus stearothermophilus Uncharacterized protein in gldA 3'region Proteins 0.000 abstract 1
- 101000976889 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 19.2 kDa protein in cox-rep intergenic region Proteins 0.000 abstract 1
- 101000827627 Klebsiella pneumoniae Putative low molecular weight protein-tyrosine-phosphatase Proteins 0.000 abstract 1
- 101001130841 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF5 Proteins 0.000 abstract 1
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 abstract 1
- 101710130262 Probable Vpr-like protein Proteins 0.000 abstract 1
- 101000974028 Rhizobium leguminosarum bv. viciae (strain 3841) Putative cystathionine beta-lyase Proteins 0.000 abstract 1
- 101000756519 Rhodobacter capsulatus (strain ATCC BAA-309 / NBRC 16581 / SB1003) Uncharacterized protein RCAP_rcc00048 Proteins 0.000 abstract 1
- 101000948219 Rhodococcus erythropolis Uncharacterized 11.5 kDa protein in thcD 3'region Proteins 0.000 abstract 1
- 101000936711 Streptococcus gordonii Accessory secretory protein Asp4 Proteins 0.000 abstract 1
- 101000929863 Streptomyces cinnamonensis Monensin polyketide synthase putative ketoacyl reductase Proteins 0.000 abstract 1
- 101000788468 Streptomyces coelicolor Uncharacterized protein in mprR 3'region Proteins 0.000 abstract 1
- 101000845085 Streptomyces violaceoruber Granaticin polyketide synthase putative ketoacyl reductase 1 Proteins 0.000 abstract 1
- 101000711771 Thiocystis violacea Uncharacterized 76.5 kDa protein in phbC 3'region Proteins 0.000 abstract 1
- 101000711318 Vibrio alginolyticus Uncharacterized 11.6 kDa protein in scrR 3'region Proteins 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 229940031348 multivalent vaccine Drugs 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16741—Use of virus, viral particle or viral elements as a vector
- C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9514450A FR2741806B1 (fr) | 1995-11-30 | 1995-11-30 | Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE420190T1 true ATE420190T1 (de) | 2009-01-15 |
Family
ID=9485221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96939150T ATE420190T1 (de) | 1995-11-30 | 1996-11-19 | Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US6074649A (de) |
| EP (1) | EP0870046B1 (de) |
| JP (2) | JP3972218B2 (de) |
| AT (1) | ATE420190T1 (de) |
| AU (1) | AU725846B2 (de) |
| BR (1) | BR9611845A (de) |
| CA (1) | CA2239072C (de) |
| DE (1) | DE69637807D1 (de) |
| DK (1) | DK0870046T3 (de) |
| ES (1) | ES2320938T3 (de) |
| FR (1) | FR2741806B1 (de) |
| NZ (1) | NZ322526A (de) |
| PT (1) | PT870046E (de) |
| WO (1) | WO1997020059A1 (de) |
| ZA (1) | ZA969951B (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002112770A (ja) | 2000-10-05 | 2002-04-16 | Kyoritsu Seiyaku Kk | 新規組換えネコヘルペスウイルス１型およびこれを用いた多価ワクチン |
| US20040241723A1 (en) * | 2002-03-18 | 2004-12-02 | Marquess Foley Leigh Shaw | Systems and methods for improving protein and milk production of dairy herds |
| EP2390352A1 (de) | 2003-03-18 | 2011-11-30 | Quantum Genetics Ireland Limited | Systeme und Methoden zur Erhöhung der Milchproduktion bei Tieren |
| US7468273B2 (en) | 2003-05-01 | 2008-12-23 | Meial Limited | Canine GHRH gene, polypeptides and methods of use |
| AU2004269320B2 (en) | 2003-06-20 | 2009-12-24 | Protein Sciences Corporation | Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
| US20050214316A1 (en) | 2003-11-13 | 2005-09-29 | Brown Thomas P | Methods of characterizing infectious bursal disease virus |
| EP1718770B1 (de) | 2004-02-19 | 2011-05-25 | The Governors of the University of Alberta | Leptinpromotor-polymorphismen und verwendungen davon |
| RS51324B (sr) | 2005-04-25 | 2010-12-31 | Merial Ltd. | Vakcine protiv nipah virusa |
| US20080241184A1 (en) | 2005-08-25 | 2008-10-02 | Jules Maarten Minke | Canine influenza vaccines |
| US7771995B2 (en) | 2005-11-14 | 2010-08-10 | Merial Limited | Plasmid encoding human BMP-7 |
| CA2629522A1 (en) | 2005-11-14 | 2007-05-18 | Merial Limited | Gene therapy for renal failure |
| US7790203B2 (en) * | 2005-12-13 | 2010-09-07 | Lowder Tom R | Composition and regimen for the treatment of herpes simplex virus, herpes zoster, and herpes genitalia epidermal herpetic lesions |
| US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
| WO2009051823A2 (en) * | 2007-10-18 | 2009-04-23 | Michigan State University | Bacterial artificial chromosome containing feline herpes virus type 1 genome and uses thereof |
| CN103585643A (zh) | 2009-04-03 | 2014-02-19 | 梅里亚有限公司 | 运载新城疫病毒的禽疫苗 |
| WO2012030720A1 (en) | 2010-08-31 | 2012-03-08 | Merial Limited | Newcastle disease virus vectored herpesvirus vaccines |
| WO2012090073A2 (en) | 2010-12-30 | 2012-07-05 | The Netherlands Cancer Institute | Methods and compositions for predicting chemotherapy sensitivity |
| AU2012240246A1 (en) | 2011-04-04 | 2013-05-09 | Netherlands Cancer Institute | Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors |
| US20140296248A1 (en) | 2011-04-04 | 2014-10-02 | Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis | Methods and compositions for predicting resistance to anticancer treatment |
| WO2012145577A1 (en) | 2011-04-20 | 2012-10-26 | Merial Limited | Adjuvanted rabies vaccine with improved viscosity profile |
| AP2013007180A0 (en) | 2011-04-25 | 2013-10-31 | Advanced Bioscience Lab Inc | Truncated HIV envelope proteins (ENV), methods andcompositions related thereto |
| EP2714077B1 (de) | 2011-06-01 | 2018-02-28 | Merial, Inc. | Nadellose verabreichung von prrsv-impfstoffen |
| LT2741740T (lt) | 2011-08-12 | 2017-08-10 | Merial, Inc. | Biologinių produktų, ypatingai vakcinų, vakuuminis konservavimas |
| WO2013093629A2 (en) | 2011-12-20 | 2013-06-27 | Netherlands Cancer Institute | Modular vaccines, methods and compositions related thereto |
| WO2013138776A1 (en) | 2012-03-16 | 2013-09-19 | Merial Limited | Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
| EP2968514A1 (de) | 2013-03-12 | 2016-01-20 | Merial, Inc. | Mittels reverser genetik hergestellte impfstoffzusammensetzungen gegen schmallenberg-virus und verfahren zur verwendung davon |
| WO2016073410A1 (en) | 2014-11-03 | 2016-05-12 | Merial, Inc. | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
| ES3050936T3 (en) | 2015-06-23 | 2025-12-23 | Boehringer Ingelheim Vetmedica Gmbh | Prrsv minor protein-containing recombinant viral vectors and methods of making and use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0427788B1 (de) * | 1988-08-08 | 1995-11-22 | The Upjohn Company | Verfahren zur isolierung für thymidin-kinase der herpesvirus kodierenden dns |
| ATE119545T1 (de) * | 1989-07-21 | 1995-03-15 | Upjohn Co | Felincalicivirus-capsid-protein und nukleotidsequenz. |
| FR2659349B1 (fr) * | 1990-03-12 | 1993-12-24 | Rhone Merieux | Virus herpes recombinants notamment pour la realisation de vaccins, leur procede de preparation, les plasmides realises au cours de ce procede et les vaccins obtenus. |
| DE69332393T2 (de) * | 1992-06-26 | 2003-06-18 | Akzo Nobel N.V., Arnheim/Arnhem | Rekombinanter Katzen-Herpesvirus-Impfstoff |
| ATE227775T1 (de) * | 1992-07-30 | 2002-11-15 | Akzo Nobel Nv | Impfstoff-vektoren von rekombinantem katzen- herpesvirus |
| GB2316681B (en) * | 1993-09-16 | 1998-04-15 | Dimminaco Ag Sa Ltd | Antigenically active proteins/polypeptides and coronavirus vaccines containing the same |
| AU2234995A (en) * | 1994-04-29 | 1995-11-29 | Pharmacia & Upjohn Company | Feline immunodeficiency virus vaccine |
-
1995
- 1995-11-30 FR FR9514450A patent/FR2741806B1/fr not_active Expired - Lifetime
-
1996
- 1996-11-19 ES ES96939150T patent/ES2320938T3/es not_active Expired - Lifetime
- 1996-11-19 CA CA2239072A patent/CA2239072C/en not_active Expired - Lifetime
- 1996-11-19 NZ NZ322526A patent/NZ322526A/en not_active IP Right Cessation
- 1996-11-19 EP EP96939150A patent/EP0870046B1/de not_active Expired - Lifetime
- 1996-11-19 DK DK96939150T patent/DK0870046T3/da active
- 1996-11-19 WO PCT/FR1996/001830 patent/WO1997020059A1/fr not_active Ceased
- 1996-11-19 AT AT96939150T patent/ATE420190T1/de active
- 1996-11-19 PT PT96939150T patent/PT870046E/pt unknown
- 1996-11-19 AU AU76301/96A patent/AU725846B2/en not_active Expired
- 1996-11-19 DE DE69637807T patent/DE69637807D1/de not_active Expired - Lifetime
- 1996-11-19 BR BR9611845A patent/BR9611845A/pt not_active Application Discontinuation
- 1996-11-19 JP JP52022497A patent/JP3972218B2/ja not_active Expired - Lifetime
- 1996-11-27 ZA ZA9609951A patent/ZA969951B/xx unknown
-
1998
- 1998-05-15 US US09/080,044 patent/US6074649A/en not_active Expired - Lifetime
-
2000
- 2000-03-21 US US09/531,857 patent/US6387376B1/en not_active Expired - Lifetime
-
2006
- 2006-08-14 JP JP2006221192A patent/JP2006320337A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PT870046E (pt) | 2009-04-13 |
| FR2741806B1 (fr) | 1998-02-20 |
| WO1997020059A1 (fr) | 1997-06-05 |
| JP2006320337A (ja) | 2006-11-30 |
| EP0870046A1 (de) | 1998-10-14 |
| BR9611845A (pt) | 1999-03-09 |
| DE69637807D1 (de) | 2009-02-26 |
| CA2239072C (en) | 2012-04-24 |
| ES2320938T3 (es) | 2009-05-29 |
| US6387376B1 (en) | 2002-05-14 |
| CA2239072A1 (en) | 1997-06-05 |
| AU725846B2 (en) | 2000-10-19 |
| JP2000501927A (ja) | 2000-02-22 |
| AU7630196A (en) | 1997-06-19 |
| DK0870046T3 (da) | 2009-05-11 |
| JP3972218B2 (ja) | 2007-09-05 |
| US6074649A (en) | 2000-06-13 |
| NZ322526A (en) | 2000-07-28 |
| EP0870046B1 (de) | 2009-01-07 |
| ZA969951B (en) | 1998-05-27 |
| FR2741806A1 (fr) | 1997-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69637807D1 (de) | Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen | |
| AR042378A2 (es) | Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de dicho poxvirus para preparar una vacuna eficaz contra la infeccion del virus de inmunodeficiencia felina | |
| AU2196592A (en) | Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits | |
| MX9203379A (es) | Proteinas producidas por los linfocitos humanos, secuencia de adn que codifica para estas proteinas y composiciones farmaceuticas que las contienen. | |
| DE69535125D1 (de) | Impstoff gegen felines immunodefizienz-virus | |
| ATE233101T1 (de) | Polynukleotide vakzine gegen den papilloma virus | |
| ES2143507T3 (es) | Vacunas contra la enfermedad de aujeszky y de otras enfermedades animales que contienen mutantes del virus de la pseudorrabia. | |
| EP0652287A3 (de) | Poxvirusvektoren und deren Anwendung als Impstoff gegen Katzenansteckende Peritonitis-Viruskrankheit. | |
| DE69737058D1 (de) | Rekombinante hunde-herpesviren | |
| DK0817851T5 (da) | DNA, der koder for humant papillomvirus type 18 | |
| PT868522E (pt) | Virus recombinante de poxvirus - virus da peritonite infecciosa felina, suas composicoes e metodos para a sua preparacao e utilizacao | |
| DE59209773D1 (de) | Equine Herpesviren (EHV), die Fremd-DNA enthalten, Verfahren zu ihrer Herstellung und ihre Verwendung in Impfstoffen | |
| ATE323767T1 (de) | Impfstoff für die infektiöse peritonitis der katzen | |
| ATE346087T1 (de) | Hepatitis e-virus aus dem schwein und dessen verwendungen | |
| DE69417717D1 (de) | Impstoff zum Schutze von Pferden gegen Pferdeherpesvirus-Infektionen | |
| ES2105984A1 (es) | Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas. | |
| FI902814A0 (fi) | Proteiner, vaccin och nukleinsyror. | |
| DK128687D0 (da) | Proteiner samt deres fremstilling og anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0870046 Country of ref document: EP |